C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2002
10/22/2002	US6468772 Methods of making modified polypeptides
10/22/2002	US6468771 Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal DNA of target cells
10/22/2002	US6468762 High specificity homocysteinases
10/22/2002	US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002	US6468750 Cell regulation factor TTO 20
10/22/2002	US6468747 Presence of the bar gene under control of a camv 35s promoter,
10/22/2002	US6468546 Compositions and methods for therapy and diagnosis of ovarian cancer
10/22/2002	US6468529 Fab fragment of a monoclonal antibody; binds to c-met receptor; cancer treatment
10/22/2002	US6468432 Methods of modification of selected cells in a magnetic cell separation column
10/22/2002	CA2216601C Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/22/2002	CA2188447C Recombinant poxviruses with foreign polynucleotides in essential regions
10/22/2002	CA2185712C Enhanced virus-mediated dna transfer
10/22/2002	CA2147989C Enhancement of xenograft tolerance and porcine cytokines therefor
10/22/2002	CA2095335C Cell growth inhibitors
10/22/2002	CA1341395C Preparation of functional human factor viii
10/17/2002	WO2002082091A2 Method for identification of proteins from intracellular bacteria
10/17/2002	WO2002082077A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	WO2002082041A2 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002	WO2002081754A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002	WO2002081751A2 A method of increasing endogenous leptin production
10/17/2002	WO2002081709A2 Modified hpv e6 and e7 genes and proteins useful for vaccination
10/17/2002	WO2002081707A1 Genetic modification of plants for enhanced resistance and decreased uptake of heavy metals
10/17/2002	WO2002081703A2 Mitogenic oxygenase regulators
10/17/2002	WO2002081681A1 Novel use of cytokine sf20
10/17/2002	WO2002081677A2 Improved gene expression
10/17/2002	WO2002081668A2 Desaturase genes and uses thereof
10/17/2002	WO2002081665A2 Implantation serine proteinases
10/17/2002	WO2002081664A2 Use of nucleosides, nucleobases and derivatives thereof for improved production of adult stem cells
10/17/2002	WO2002081663A1 Process for producing nerve stem cells, motor neurons and gabaergic neurons from embryonic stem cells
10/17/2002	WO2002081662A1 Methods and gel compositions for encapsulating living cells and organic molecules
10/17/2002	WO2002081661A2 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
10/17/2002	WO2002081660A1 Compositions and method for enhancing proteoglycan production
10/17/2002	WO2002081648A2 Synthesis and secretion of recombinant lysosomal enzymes by liver
10/17/2002	WO2002081647A2 Bioluminescent plants and methods of making same
10/17/2002	WO2002081646A2 Epitope sequences
10/17/2002	WO2002081636A2 Protein modification and maintenance molecules
10/17/2002	WO2002081632A2 Nucleic acids for transgene expression
10/17/2002	WO2002081628A2 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies
10/17/2002	WO2002081626A2 D-hydantoinase from ochrobactrum anthropi
10/17/2002	WO2002081619A1 Glycosaminoglycan/collagen complexes and use thereof
10/17/2002	WO2002081523A2 Method for preparing and selecting antibodies
10/17/2002	WO2002081519A2 Ifn-thy fusion protein,dna coding therefore,its preparation and application
10/17/2002	WO2002081515A1 Insulin-like growth factor-binding protein
10/17/2002	WO2002081513A2 Disease-associated protein
10/17/2002	WO2002081507A2 Interferon gamma polypeptide variants
10/17/2002	WO2002081496A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
10/17/2002	WO2002081494A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
10/17/2002	WO2002081492A1 Human gene critical to fertility
10/17/2002	WO2002081007A2 Methods of isolating blood components using a centrifuge and uses thereof
10/17/2002	WO2002080995A1 Scaffold matrix and tissue maintaining systems
10/17/2002	WO2002080992A1 Chitosan and hydroxy carboxylic acid based porous and non-porous matrices
10/17/2002	WO2002080852A2 Genes expressed in intestinal epithelium and peyer's patch m cells
10/17/2002	WO2002080851A2 Chimeric vaccines
10/17/2002	WO2002080849A2 Chemotherapeutic induction of egr-1 promoter activity
10/17/2002	WO2002080845A2 Novel eps8 compounds for therapy and diagnosis and methods for using same
10/17/2002	WO2002080844A2 Novel bgp compounds for therapy and diagnosis and methods for using same
10/17/2002	WO2002080670A1 Device for preparing cells for cryopreservation
10/17/2002	WO2002063036A3 Vector system used in screening active substances
10/17/2002	WO2002062969A9 Cellular reprogramming in peptide hydrogel and uses thereof
10/17/2002	WO2002060924A3 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
10/17/2002	WO2002059140A3 Ikaros rgulatory elements and uses thereof
10/17/2002	WO2002040700A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
10/17/2002	WO2002040665A3 Complementing cell lines
10/17/2002	WO2002038607A3 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
10/17/2002	WO2002036733A9 Cd36 as a heat shock protein receptor and uses thereof
10/17/2002	WO2002029061A3 G-protein coupled receptors
10/17/2002	WO2002016555A3 Htert-immortalised cell lines, their preparation and use
10/17/2002	WO2002016417A3 Transgenic animal model for neurodegerative disease and uses thereof
10/17/2002	WO2002012463A3 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
10/17/2002	WO2002004489A9 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/17/2002	WO2002000871A3 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current
10/17/2002	WO2001098354A3 Human receptors
10/17/2002	WO2001098323A3 G-protein coupled receptors
10/17/2002	WO2001096585A3 Modulation of abscisic acid signal transduction in plants
10/17/2002	WO2001090151A3 Human receptor proteins; related reagents and methods
10/17/2002	WO2001081551A3 Retinal pigment epithelial cell lines with extended life-span and their applications
10/17/2002	WO2001075077A3 Isolation and expression of a gene for a nitrilase from acidovorax facilis 72w
10/17/2002	WO2001058931A9 Method of treating disorders of the eye
10/17/2002	WO2001056379A9 A method of quieting a corneal inflammatory response
10/17/2002	WO2001042423A9 Compositions and methods for detecting stress-inducible proteins
10/17/2002	US20020152496 Coleopteran toxin proteins of bacillus thuringiensis
10/17/2002	US20020152490 Tolerance-inducing thy-marrow composite tissue construct and organ
10/17/2002	US20020152487 Transgenic animal; controlling transcription factor; administering tetracyclic promoter
10/17/2002	US20020152485 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/17/2002	US20020152484 Human t cell-engrafted mouse, method for developing same and use thereof
10/17/2002	US20020152483 Genetic engineering; prevention fat accumulation
10/17/2002	US20020152481 Genetic engineering; qualitative analysis
10/17/2002	US20020151974 Tympanic membrane patch
10/17/2002	US20020151706 Antiinflammatory agents
10/17/2002	US20020151699 Transgenic; gene expression; cloning; isolation of ricinoleic acid from oleic acid in developing endosperm of castor
10/17/2002	US20020151698 For diagnosis, prevention, and treatment of cancer, and neurological and immune disorders
10/17/2002	US20020151695 Transforming growth factor-beta-related molecules and uses thereof
10/17/2002	US20020151694 Release of intracellular material
10/17/2002	US20020151690 Generating antigen preferential lymphocytes; obtainlymphocytes, apply to matrix, elute preferential cells from matrix
10/17/2002	US20020151689 Method of killing target cells in harvested cell populations with one or more immuno-toxins
10/17/2002	US20020151680 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/17/2002	US20020151679 Peptide for use in the treatment of infections, viral and cancer diseases
10/17/2002	US20020151517 Administering to the mammal nucleosomes(a complex of DNA and histones) that elicit the production of antinuclear autoantibodies sufficient to inhibit neoplastic cell growth
10/17/2002	US20020151498 Medicaments that modify activity of Lipolysis Stimulated Receptor and that can be used to influence partitioning of dietary lipids between liver and peripheral tissues, including adipose tissue
10/17/2002	US20020151494 Novel amino acid sequences for human semaphorin-like polypeptides

1 ... 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 ... 1827